NYSE:AIM

Aim Immunotech Stock Predictions

etoro logo Buy AIM
*Your capital is at risk
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

AIM Prediction Chart

AIM Predictions History

Latest community submissions for AIM.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 6, 2025 $1.87 +7.54% $1.67 X 88.19% 0
Nov 6, 2025 $1.84 +5.88% $1.67 X 89.93% 0
Nov 6, 2025 $2.40 +54.65% $1.67 V 56.29% 0
Oct 27, 2025 $2.68 +0.09% $2.62 V 97.73% 1
Oct 27, 2025 $2.71 +1.22% $2.62 V 96.58% 1
Oct 27, 2025 Bullish $2.62 X 0
Apr 25, 2025 $0.0924 +40.13% $0.0949 X 97.39% 0
Apr 25, 2025 $0.0934 +41.54% $0.0949 X 98.37% 0
Apr 25, 2025 Bullish $0.0949 V 0
Feb 19, 2025 $0.145 +8.86% $0.134 V 91.97% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AIM with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AIM IMMUNOTECH INC.
AIM ImmunoTech
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, n...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE